Recall underway


recall regulatory
Recall notice issued for several Zantac brands following contamination fear The TGA is advising consumers and health professionals that several ranitidine-containing products have been removed from the Australian market due to contamination with an impurity called N‑nitrosodimethylamine (NDMA). "Ranitidine tablets and oral liquids are now in short supply as a number of commonly-used brands have been

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Self-care: 14 professional responsibilities
Next Pain and opioids and the bigger picture